FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Liotrix (Thyrolar) Tablets
Status: Discontinuation
»Therapeutic Categories: Endocrinology/Metabolism

Expand all

Allergan (New 12/06/2018)

Company Contact Information:
800-678-1605

Presentation Posting Date Related Information
Thyrolar-1/4 (NDC 0456-0040-01) 12/06/2018 The company has made a business decision to discontinue manufacturing of Thyrolar® (Liotrix tablets, USP) ¼, ½, 1, 2 and 3 grains
Thyrolar-1/2 (NDC 0456-0045-01) 12/06/2018 The company has made a business decision to discontinue manufacturing of Thyrolar® (Liotrix tablets, USP) ¼, ½, 1, 2 and 3 grains
Thyrolar-1 (NDC 0456-0050-01) 12/06/2018 The company has made a business decision to discontinue manufacturing of Thyrolar® (Liotrix tablets, USP) ¼, ½, 1, 2 and 3 grains
Thyrolar-2 (NDC 0456-0055-01) 12/06/2018 The company has made a business decision to discontinue manufacturing of Thyrolar® (Liotrix tablets, USP) ¼, ½, 1, 2 and 3 grains
Thyrolar-3 (NDC 0456-0060-01) 12/06/2018 The company has made a business decision to discontinue manufacturing of Thyrolar® (Liotrix tablets, USP) ¼, ½, 1, 2 and 3 grains

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English